SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-001356
Filing Date
2023-01-13
Accepted
2023-01-13 09:00:14
Documents
18
Period of Report
2023-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51090
2 ex4-1.htm EX-4.1 97701
3 ex10-1.htm EX-10.1 224880
4 ex10-2.htm EX-10.2 222996
5 ex4-1_001.jpg GRAPHIC 3871
6 ex10-1_001.jpg GRAPHIC 2124
7 ex10-2_001.jpg GRAPHIC 2124
  Complete submission text file 0001493152-23-001356.txt   878081

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE orgs-20230110.xsd EX-101.SCH 3230
9 XBRL LABEL FILE orgs-20230110_lab.xml EX-101.LAB 34916
10 XBRL PRESENTATION FILE orgs-20230110_pre.xml EX-101.PRE 22791
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3619
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 23527384
SIC: 2834 Pharmaceutical Preparations